All patients except for the RAD51C and FH heterozygotes, were referred to the NIH without prior knowledge of their germline status and had been followed according to the chordoma screening protocol, as recommended in the published guidelines by the Chordoma Global Consensus Group in 2017 (Stacchiotti et al. 2017). The gene discussed is FH; the disease is chordoma.